[go: up one dir, main page]

De Flora et al., 1991 - Google Patents

Antioxidant activity and other mechanisms of thiols involved in chemoprevention of mutation and cancer

De Flora et al., 1991

Document ID
4739332871107372964
Author
De Flora S
Izzotti A
D'Agostini F
Cesarone C
Publication year
Publication venue
The American journal of medicine

External Links

Snippet

Our studies provide evidence that thiols, such as N-acetyl-l-cysteine, inhibit both spontaneous mutations and induced mutations in bacteria, prevent the in vivo formation of carcinogen-DNA adducts, and suppress or delay the development of tumors or …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides

Similar Documents

Publication Publication Date Title
De Flora et al. Antioxidant activity and other mechanisms of thiols involved in chemoprevention of mutation and cancer
De Flora et al. Chemopreventive properties and mechanisms of N‐acetylcysteine. The experimental background
Pascale et al. Chemoprevention of hepatocarcinogenesis: S-adenosyl-L-methionine
Kumar et al. Redox homeostasis in mycobacteria: the key to tuberculosis control?
Sengottuvelan et al. Modulatory influence of dietary resveratrol during different phases of 1, 2-dimethylhydrazine induced mucosal lipid-peroxidation, antioxidant status and aberrant crypt foci development in rat colon carcinogenesis
Kalpana et al. Modulatory effects of curcumin on lipid peroxidation and antioxidant status during nicotine-induced toxicity.
Basaga et al. Free radical scavenging and antioxidative properties of ‘silibin’complexes on microsomal lipid peroxidation
Karthick et al. Preventive effect of rutin, a bioflavonoid, on lipid peroxides and antioxidants in isoproterenol‐induced myocardial infarction in rats
Devaki et al. Stabilization of mitochondrial and microsomal function by polysaccharide of Ulva lactuca on d-Galactosamine induced hepatitis in rats
Wu et al. Reactive oxygen species and gastric carcinogenesis: the complex interaction between Helicobacter pylori and host
Izzotti et al. Chemoprevention of carcinogen-DNA adducts and chronic degenerative diseases
Kasprzak et al. Inhibition of antimutagenic enzymes, 8-oxo-dGTPases, by carcinogenic metals. Recent developments
De Flora et al. Prevention by N-acetylcysteine of benzo [a] pyrene clastogenicity and DNA adducts in rats
Büyükokuroğlu et al. Prevention of acute adriamycin cardiotoxicity by dantrolene in rats
O'Brian et al. Involvement of cytochromes and a flavoprotein in hydrogen oxidation in Rhizobium japonicum bacteroids
JP2007537246A (en) Cancer preventive and therapeutic agent containing nicotinic acid derivative as active ingredient
Izzotti et al. Formation of DNA adducts in the aorta of smoke-exposed rats, and modulation by chemopreventive agents
Olinski et al. Viral infection-oxidative stress/DNA damage-aberrant DNA methylation: separate or interrelated events responsible for genetic instability and childhood ALL development?
Ajith et al. Chemopreventive activity of a macrofungus Phellinus rimosus against N-nitrosodiethylamine induced hepatocellular carcinoma in rat.
Wai et al. Streptomyces barringtoniae sp. nov., isolated from rhizosphere of plant with antioxidative potential
Iwamoto et al. Oxidative DNA damage induced by photodegradation products of 3′-azido-3′-deoxythymidine
De Flora et al. Inhibition of mutagenesis and carcinogenesis by N-acetylcysteine
Grant et al. Effect of tetrahydrouridine and deoxytetrahydrouridine on the interaction between 2′-deoxycytidine and 1-β-d-arabinofuranosylcytosine in human leukemia cells
US6043256A (en) Antimutagenic agents
EP1003508B1 (en) Antimutagenic agents